Reckitt Benckiser to switch Boots account
Reckitt Benckiser is expected to switch the £11m ad account for Boots’ over-the-counter medicines from McCann Erickson following its £1.9bn acquisition of Boots Health Care International.
Reckitt Benckiser is expected to switch the &£11m ad account for Boots’ over-the-counter medicines from McCann Erickson following its &£1.9bn acquisition of Boots Health Care International. The account is expected to be moved to its roster agencies, which includes JWT and Euro RSCG.
